AstraZeneca Affiliate Hit With $275M Merger Payment Suit
Agents for the former shareholders of a pharmaceutical company acquired by an affiliate of AstraZeneca PLC filed suit Thursday in Delaware state court seeking the payment of $275 million they allege...To view the full article, register now.
Already a subscriber? Click here to view full article